Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil

Nolan Francis; Brittany G. Craiglow

doi:10.1111/pde.70049

September 26, 2025Pediatric Dermatology

Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil

View at Publisher

Ask AI

Bookmark

Share

Key Points

Treatment with low-dose oral minoxidil resulted in significant hair growth improvements in both pediatric patients.
The findings illustrate the effectiveness of low-dose oral minoxidil as a treatment option for short anagen syndrome.
Two patients diagnosed with short anagen syndrome showed favorable responses to the new treatment.
This case report highlights an emerging therapeutic approach for pediatric hair disorders, enhancing hair growth.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Case reports reveal positive outcomes of low-dose oral minoxidil in treating short anagen syndrome, suggesting its potential in pediatric hair disorders.

Abstract

Short anagen syndrome (SAS) is a rare condition characterized by a shortened anagen phase, resulting in an inability to grow long scalp hair. Low‐dose oral minoxidil (LDOM) has recently emerged as an effective treatment for a variety of pediatric hair disorders. This report presents two pediatric patients with SAS who responded favorably to treatment with LDOM.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Francis et al. (2025) studied this question.

synapsesocial.com/papers/68d9051b41e1c178a14f4ef2 https://doi.org/10.1111/pde.70049

View at Publisher

Ask AI

Bookmark

Share

Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading